Upstream Processing

Jan 09, 2015
By BioPharm International Editors
Single-use components will be used in automated personalized therapy manufacturing.
BioPharm International: Jan 01, 2015
Improving efficiency, value chain, quality, and protein complexity with advanced bioprocess development.
Dec 23, 2014
By BioPharm International Editors
Protein Sciences will evaluate sourcing Flublok from its Japanese licensee, UMN Pharma, which already runs a large-scale facility for the vaccine.
Dec 19, 2014
By BioPharm International Editors
The Cell Therapy Catapult, a UK non-profit center for advancing cell and gene therapies, will manage the manufacturing center, which will be used for late-phase clinical trials and commercial supply.
BioPharm International: Oct 31, 2014
Challenges remain for virus removal and validation.
BioPharm International: Sep 30, 2014
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
BioPharm International: Aug 31, 2014
Careful selection of downstream processing conditions is a must.
BioPharm International: Apr 30, 2014
New human and plant-based expressions systems can enable faster product development and improve quality at potentially lower costs.
BioPharm International: Apr 30, 2014
New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.
Mar 31, 2014
A review of the past year's trends in biopharmaceutical approvals shows an above average approval rate.